Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
CMAJ ; 192(49): E1784, 2020 Dec 07.
Article in French | MEDLINE | ID: mdl-33288518
3.
Clin Interv Aging ; 9: 2133-41, 2014.
Article in English | MEDLINE | ID: mdl-25584025

ABSTRACT

PURPOSE: The number of elderly inpatients has been steadily increasing worldwide. However, the ability to predict the degree of improvement of functional capacity after comprehensive examination of elderly inpatients is still lacking. The purpose of this study was to investigate the predictors of improved functional outcome after rehabilitation of elderly inpatients. METHODS: We performed a retrospective cohort study with 1,079 patients (age <70 years: N=331, age ≥70 years: N=748) who had been admitted to Tottori Municipal Hospital. Functional Independence Measure (FIM) scores were measured both at admission and discharge to calculate FIM gain and efficiency. Of these patients, 262 patients had oral examinations on admission. The Mann-Whitney U-test or chi-square test was used for statistical analyses. Conditional logistic regression analysis was used to compute the odds ratio (OR) and 95% confidence interval (CI). Cut-off values of FIM scores to determine if elderly inpatients were able to return home after discharge were determined using a receiver operating characteristic curve. RESULTS: FIM scores, including FIM gain and efficiency, of elderly patients were significantly lower than those of middle-aged patients. Inability to close the lips and dysfunctional tongue movement, but not the loss of teeth, were correlated with a reduced improvement of FIM scores. Cognitive impairment and aspiration pneumonia, but not cerebrovascular disease, were also correlated with a reduced improvement of FIM scores. Interestingly, FIM scores were significantly lower in patients with both cerebrovascular disease and a loss of posterior occlusion. Factors shown to have a significant impact on the improvement of FIM scores included the stable posterior occlusion (OR: 2.23, 95% CI: 1.2-4.1), closed lips (OR: 5.15, 95% CI: 2.3-11.7), functional tongue movement (OR: 5.74, 95% CI: 3.0-11.0), presence of cognitive impairment (OR: 0.31, 95% CI: 0.17-0.49), and presence of aspiration pneumonia (OR: 0.27, 95% CI: 0.15-0.51). CONCLUSION: Age and disorder of oral function may be significant predictors of improved functional capacity after rehabilitation for elderly inpatients.


Subject(s)
Cerebrovascular Disorders/rehabilitation , Health Status Indicators , Outcome Assessment, Health Care , Patient Admission/statistics & numerical data , Patient Discharge/statistics & numerical data , Aged , Aged, 80 and over , Cohort Studies , Female , Geriatric Assessment , Humans , Logistic Models , Male , Middle Aged , Recovery of Function , Retrospective Studies , Treatment Outcome
4.
Clin Neurol Neurosurg ; 108(1): 80-3, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16311154

ABSTRACT

Epstein-Barr virus (EBV) infection causes a wide range of neurologic and hematologic manifestations. We report a 72-year-old Japanese male patient with severe chronic active EBV infection syndrome (SCAEBV) who presented with Guillain-Barré syndrome (GBS) and developed hemophagocytic lymphohistiocytosis (HLH) several months after the onset of GBS. He showed acute onset of distal muscle weakness, ophthalmoplegia and bulbar palsy. Results of nerve conduction study revealed acute motor-sensory axonal neuropathy (AMSAN). His serum was positive for anti-LM1 IgG and anti-GM1b IgM. Titers of antibodies to EBV-related antigens indicated chronic reactivated EBV infection. Treatment with IVIg resolved the acute ophthalmoplegia, but there was no notable improvement in the AMSAN and bulbar palsy despite repeated. Finally, he developed refractory HLH resulting in a fatal outcome. In the present patient, it seems that SCAEBV was associated with the development of GBS and fatal HLH via parainfectious autoimmunity and direct infectious immune mechanisms, respectively.


Subject(s)
Epstein-Barr Virus Infections/complications , Guillain-Barre Syndrome/virology , Lymphohistiocytosis, Hemophagocytic/virology , Aged , Chronic Disease , Epstein-Barr Virus Infections/diagnosis , Epstein-Barr Virus Infections/therapy , Fatal Outcome , Guillain-Barre Syndrome/diagnosis , Guillain-Barre Syndrome/therapy , Humans , Lymphohistiocytosis, Hemophagocytic/diagnosis , Lymphohistiocytosis, Hemophagocytic/therapy , Male , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL
...